Latest Biotech News

Resalis Therapeutics presented preclinical data on an antisense oligonucleotide (ASO) targeting miR‑22 that the company says induces durable, tissue‑level metabolic changes and healthier weight...

Nurix Therapeutics implemented a targeted workforce reduction while initiating the DAYBreak pivotal Phase 2 trial of its BTK degrader bexobrutideg in relapsed/refractory chronic lymphocytic...

Legal disputes escalated between AnaptysBio and Tesaro (a GSK subsidiary) as both parties filed competing lawsuits over licensing rights and revenue tied to Jemperli. GSK/Tesaro moved to terminate...

Biotech industry leaders urged FDA Director Marty Makary for regulatory stability in a letter citing survey data that shows broad concern over agency predictability; signatories warned that...

The FDA approved Bayer’s oral HER2-directed therapy Hyrnuo (sevabertinib) for adults with locally advanced or metastatic HER2-mutant non‑small-cell lung cancer, and Thermo Fisher’s Ion Torrent...

Abbott agreed to acquire Exact Sciences in a cash deal valuing the diagnostics company at roughly $21–23 billion, moving Abbott decisively into cancer screening and precision oncology. Exact’s...

The FDA said it is hiring more than 1,000 new staffers and piloting an email 'quick clarification' program to speed sponsor interactions and reduce review uncertainty. Commissioner Marty Makary...

Eli Lilly’s market capitalization briefly exceeded $1 trillion as sales of GLP‑1 obesity and diabetes medicines propelled the company to a new valuation milestone. The surge underscores the...

Ginkgo Bioworks launched the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints to create a standardized, open dataset for virtual cell modeling in drug discovery. VCPI will...

San Diego‑based Iambic is advancing a physics‑informed, automation‑driven platform aimed at compressing the small‑molecule discovery timeline to roughly two years from chemistry to clinic. The...

France‑based Ocean Diagnostics completed a pilot clinical evaluation of a rapid blood test that identified sepsis pathogens and matched gold‑standard blood culture results at 100% while detecting...

Hepta released proof‑of‑concept data showing cell‑free DNA methylation patterns in plasma reflect liver tissue biology and fibrosis states. The company built a multiomic liver atlas with...

Contineum Therapeutics reported topline results from its Phase II VISTA study of PIPE‑307, an M1 receptor agonist developed with Janssen, and the trial missed its primary and key secondary...

Taiho Pharmaceutical and Cullinan Therapeutics began a rolling New Drug Application filing with the FDA seeking accelerated approval of zipalertinib for patients with locally advanced or...

Abbott Laboratories announced a definitive agreement to acquire Exact Sciences for roughly $21–23 billion in cash, moving the med-tech giant directly into cancer screening and precision oncology....

Eli Lilly became the first drugmaker to reach a $1 trillion market valuation, a milestone the company attributed to blockbuster revenue from its obesity and metabolic medicines. The firm’s market...

The Centers for Disease Control and Prevention revised wording on a vaccine-safety webpage to state that a causal link between childhood vaccines and autism cannot be ruled out. The update follows...

Ginkgo Bioworks’ Datapoints unit launched the Virtual Cell Pharmacology Initiative (VCPI), an open-source project to generate standardized pharmacology datasets and a reference engineered cell...

France-based Ocean Diagnostics completed a 110‑patient pilot showing its rapid bloodstream pathogen ID test matched conventional blood culture results at 100% and detected additional pathogens...

Contineum Therapeutics reported topline data from its Phase 2 VISTA trial of PIPE-307 in relapsing‑remitting multiple sclerosis and said the study failed to meet primary and key secondary...